cysteamine has been researched along with Infarction, Middle Cerebral Artery in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, R; Li, Z; Liang, F; Liu, Y; Luo, S; Pei, Z; Wang, S; Zhu, Y | 1 |
1 other study(ies) available for cysteamine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Intravenous PEP-1-GDNF is protective after focal cerebral ischemia in rats.
Topics: Animals; Brain; Brain Infarction; Cell Differentiation; Cell Proliferation; Cysteamine; Dentate Gyrus; Glial Cell Line-Derived Neurotrophic Factor; Infarction, Middle Cerebral Artery; Injections, Intravenous; Ischemic Attack, Transient; Male; Maze Learning; Neuroprotective Agents; Peptides; Rats, Sprague-Dawley; Recombinant Fusion Proteins | 2016 |